Professor in Cardiology, SCTIMST, Trivandrum, India
Joined September 2009
- Tweets 809
- Following 38
- Followers 66
- Likes 580
94 Photos and videos
Sanjay Ganapathi retweeted
Mar 6
7
33
126
89,992
Sanjay Ganapathi retweeted
24 Nov 2025
FFR is a surrogate for ischemia. Ischemia is a marker of adverse outcomes, not a cause. Revascularization of individuals with ischemia does not improve outcomes on OMT. Why do we still obsess over FFR and its derivatives?
9
10
67
13,670
Sanjay Ganapathi retweeted
16 Nov 2025
13/15
We thank everyone who were part of this. Please share our work widely, so that the public/patients get what they truly deserve. High time to stop blindly following what pharmaceutical industry has been making doctors do what they do like sheep. Time to make changes.
1
11
56
17,521
Sanjay Ganapathi retweeted
16 Nov 2025
1/15
Our important work, The Citizens Protein Project 2 that analysed "hospital/doctor" prescribed whey protein vs. nutraceutical/fitness industry marketed whey protein is now peer-reviewed and published. Please share with your doctor!
Full paper: journals.lww.com/md-journal/…
22
130
492
79,236
Sanjay Ganapathi retweeted
5 Sep 2025
New @TheLancet Meta-Analysis by #NelsonWang @BrighamWomens HF Fellow
What is the expected BP lowering with various antihypertensive regimens?
Robust model derived from n=104,176 pts across 484 RCTs
Terrific user-friendly tool: bpmodel.org/
thelancet.com/journals/lance…
5
75
200
17,421
Sanjay Ganapathi retweeted
7 Jun 2025
Congratulations to superstar @KeckMedicineUSC resident, now chief resident @ayeshasinghmd on her new paper in @JAHA_AHA . Stay tuned for more publications from her. Source: Journal of the American Heart Association share.google/Tp2b1C5qcsospE3…
1
9
31
4,024
Sanjay Ganapathi retweeted
28 May 2025
abbott.mediaroom.com/2025-05…
How many devices are approved by the FDA based on small (n<110), open-label, single-arm, non-randomized trial?
4
3
19
5,326
Sanjay Ganapathi retweeted
24 May 2025
This is the latest publication of ISCHEMIA investigators. PCI vs CABG. My opinions of the use or useless information it conveys. sciencedirect.com/science/ar…
3
31
103
19,089
Sanjay Ganapathi retweeted
14 May 2025
The Ina-RHD Multicenter Study highlights the significant burden of rheumatic heart disease in Indonesia 🇮🇩, with late-stage presentation, high prevalence of AF ⚡, and suboptimal anticoagulation 💊
🔗 Read the full article: doi.org/10.1016/j.jacasi.202…
@JACCJournals
9
33
6,354
Sanjay Ganapathi retweeted
13 May 2025
Emerging data suggests that one-size-fits-all troponin thresholds may miss the mark, especially in older adults. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#troponin #ischemic #cardiotwitter @ESC_Journals @escardio
31
67
4,613
Sanjay Ganapathi retweeted
2 Apr 2025
The reason why NI trials use a combined efficacy and safety NACE outcome is because it is typically biased towards NI (outcomes going in opposite direction cancel each other out!). Journals should know better, yet they publish these substandard studies.
2
3
243
Sanjay Ganapathi retweeted
25 Mar 2025
Engage the whole family and achieve weight reduction: a model for obesity risk reduction in LMIC. @antonystanley09 @AbrahamSBabu @gesjay @sctimst_tvm @AnnFamMed @worldheartfed @IBTNetwork @mkali_twindad @NITIAayog @PMOIndia annfammed.org/content/23/2/9…
6
11
358
Sanjay Ganapathi retweeted
25 Mar 2025
Lifestyle modification: engage the whole family, reap maximum benefits! @sctimst_tvm @gesjay @antonystanley09 @AnnFamMed epaper.newindianexpress.com/…
4
7
134
14 Dec 2024
Will there be a day with all the vehicles being driven by AI or robots, networked with every other vehicle; leading to low rates of accidents, road rages and crimes and a streamlined traffic, perhaps ?
13 Dec 2024
My Tesla FSD 13.2 drove me from Los Angeles to San Diego, and I didn't touch the steering wheel or pedals once from the parking spot in Los Angeles to the parking garage of the hotel in San Diego. Road tripping without this tech in 2024 is insane.
Sponsored by @JowuaLife
48
Sanjay Ganapathi retweeted
26 Sep 2024
The cost of Branded drugs for HF is several-fold higher than generic drugs available in Janaushadhi Kendra journals.lww.com/hfji/fullte…
@gesjay @JPNadda @PMOIndia @NITIAayog @MoHFW_INDIA @hfai20 @AyushmanNHA #HeartFailure #GenericDrugs #Janaushadhi #ayushmanbharatscheme
1
3
108
Sanjay Ganapathi retweeted
8 Jun 2024
Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Hypertrophic Cardiomyopathy Patients with Atrial Fibrillation
@EthanRowin
heartrhythmjournal.com/artic…
20
47
57,784
Sanjay Ganapathi retweeted
18 May 2024
I will start another debate on left atrial appendage occlusion. This one in Hyde Park format at #HRS2024
I have 9 reasons why I am not convinced this procedure benefits patients. This is percutaneous closure. Surgical closure was shown effective (along with AC) in LAAOS3
1/
15
69
263
118,130